| ARQT Stock | | | USD 13.24 0.43 3.15% |
Arcutis Biotherapeutics Net Loss yearly trend continues to be comparatively stable with very little volatility. Net Loss will likely drop to -4.16 in 2025.
Check out the analysis of
Arcutis Biotherapeutics Correlation against competitors.
For more information on how to buy Arcutis Stock please use our
How to Invest in Arcutis Biotherapeutics guide.
Latest Arcutis Biotherapeutics' Profit Margin Growth Pattern
Below is the plot of the Net Profit Margin of Arcutis Biotherapeutics over the last few years. It is the percentage of revenue left after all expenses have been deducted from sales. The measure is calculated by dividing net profit by revenue. Arcutis Biotherapeutics' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Arcutis Biotherapeutics' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.41) % | 10 Years Trend | | |
Arcutis Profit Margin Regression Statistics
| Arithmetic Mean | (71.60) |
| Geometric Mean | 49.29 |
| Coefficient Of Variation | (46.72) |
| Mean Deviation | 25.29 |
| Median | (87.16) |
| Standard Deviation | 33.46 |
| Sample Variance | 1,119 |
| Range | 83.2047 |
| R-Value | 0.68 |
| Mean Square Error | 648.82 |
| R-Squared | 0.46 |
| Significance | 0 |
| Slope | 4.76 |
| Total Sum of Squares | 16,789 |
Arcutis Profit Margin History
| 2025 | -4.16 | |
| 2024 | -3.96 | |
| 2023 | -4.4 | |
Other Fundumenentals of Arcutis Biotherapeutics
Arcutis Biotherapeutics Profit Margin component correlations
Click cells to compare fundamentals
About Arcutis Biotherapeutics Financial Statements
Arcutis Biotherapeutics shareholders use historical fundamental indicators, such as Profit Margin, to determine how well the company is positioned to perform in the future. Although Arcutis Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Arcutis Biotherapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Arcutis Biotherapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Arcutis Stock Analysis
When running Arcutis Biotherapeutics' price analysis, check to
measure Arcutis Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcutis Biotherapeutics is operating at the current time. Most of Arcutis Biotherapeutics' value examination focuses on studying past and present price action to
predict the probability of Arcutis Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcutis Biotherapeutics' price. Additionally, you may evaluate how the addition of Arcutis Biotherapeutics to your portfolios can decrease your overall portfolio volatility.